# Henrik Zetterberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/henrik-zetterberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 188,943 |
| Field | Alzheimer's disease research and treatments |
| h-index | 197 |
| i10-index | 1,939 |
| Last Known Institution | University of Wisconsin–Madison |
| OpenAlex ID | https://openalex.org/A5079766290 |
| ORCID iD | https://orcid.org/0000-0003-3930-4354 |
| Works | 3,778 |

## Researcher papers

Showing 12 of 24.

- [Defeating Alzheimer's disease and other dementias: a priority for European science and society](https://scholariq.org/papers/defeating-alzheimer-s-disease-and-other-dementias-a-priority-for-european/)
- [Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders](https://scholariq.org/papers/discriminative-accuracy-of-plasma-phospho-tau217-for-alzheimer-disease-vs-other/)
- [TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis](https://scholariq.org/papers/trem2-mutations-implicated-in-neurodegeneration-impair-cell-surface-transport/)
- [Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives](https://scholariq.org/papers/biomarkers-for-alzheimer-s-disease-academic-industry-and-regulatory-perspectives/)
- [Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report](https://scholariq.org/papers/resistance-to-autosomal-dominant-alzheimer-s-disease-in-an-apoe3-christchurch/)
- [Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study](https://scholariq.org/papers/plasma-phosphorylated-tau-217-and-phosphorylated-tau-181-as-biomarkers-in/)
- [Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype](https://scholariq.org/papers/duration-of-preclinical-prodromal-and-dementia-stages-of-alzheimer-s-disease-in/)
- [A Practical Guide to Immunoassay Method Validation](https://scholariq.org/papers/a-practical-guide-to-immunoassay-method-validation/)
- [Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need](https://scholariq.org/papers/perspectives-on-ethnic-and-racial-disparities-in-alzheimer-s-disease-and-related/)
- [Core candidate neurochemical and imaging biomarkers of Alzheimer's disease](https://scholariq.org/papers/core-candidate-neurochemical-and-imaging-biomarkers-of-alzheimer-s-disease/)
- [Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected](https://scholariq.org/papers/novel-tau-biomarkers-phosphorylated-at-t181-t217-or-t231-rise-in-the-initial/)
- [The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers](https://scholariq.org/papers/the-alzheimer-s-association-external-quality-control-program-for-cerebrospinal/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [S100 Proteins and Annexins](https://scholariq.org/topics/s100-proteins-and-annexins/)

## Researcher university

- [University of Wisconsin–Madison](https://scholariq.org/institutions/university-of-wisconsin-madison/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.